Showing results (231-240 of 418) with videos related to

Sort By:
Pageof 42
The American Journal of Pathology|August 26, 2003
Detection of oncofetal h19 RNA in rheumatoid arthritis synovial tissueBruno Stuhlmüller, Elke Kunisch, Juliane Franz, et al.
Annals of the Rheumatic Diseases|March 3, 2007
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trialGerd R Burmester, Xavier Mariette, Carlomaurizio Montecucco, et al.
Annals of the Rheumatic Diseases|October 28, 2021
Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated databasePeter C Taylor, Tsutomu Takeuchi, Gerd R Burmester, et al.
Experimental Cell Research|July 6, 2010
Novel markers of mesenchymal stem cells defined by genome-wide gene expression analysis of stromal cells from different sourcesNikolas Kaltz, Jochen Ringe, Christina Holzwarth, et al.
Mediators of Inflammation|March 28, 2015
Cardiac migration of endogenous mesenchymal stromal cells in patients with inflammatory cardiomyopathyCaroline Schmidt-Lucke, Felicitas Escher, Sophie Van Linthout, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 24, 2018
Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody: Long-Term Safety and Efficacy in Patients With Rheumatoid ArthritisGerd R Burmester, Iain B McInnes, Joel M Kremer, et al.
Annals of the Rheumatic Diseases|December 21, 2012
The role of biosimilars in the treatment of rheumatic diseasesThomas Dörner, Vibeke Strand, Gilberto Castañeda-Hernández, et al.
Arthritis Research & Therapy|February 24, 2009
Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohortKatharina Hanke, Cornelia Dähnrich, Claudia S Brückner, et al.
Arthritis and Rheumatism|August 1, 2008
Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-makingAnnette H M van der Helm-van Mil, Jacqueline Detert, Saskia le Cessie, et al.
Clinical and Experimental Rheumatology|March 3, 2022
Rare within rare. Necrotising scleritis and peripheral ulcerative keratitis: eye-threatening complications of relapsing polychondritisLaura Damian, Cristina Pamfil, Camelia Bucșa, et al.
Pageof 42